Pre-Open Stock Movers 06/09: (AEMD) (WISH) (SLDB) Higher; (ODNS) (CPB) (CMTL) Lower (more...)
- Dow, S&P post worst week in months after hawkish Fed spooks investors
- Fed-fueled dollar rises as bears make for exits
- Adobe (ADBE) Edges Higher After Topping Q2 Estimates, Analysts Raise PT on 'Impressive' Performance
- Fed Statement Very Bullish for Tech Stocks, Focus on Cloud and Cyber Stocks - Wedbush
- You Fight Real Physical Inflation With Rate Hikes, Not Talk of Rate Hikes; Buy the Dip in Commodities, Gold Underpriced - Goldman Sachs
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Pre-Open Stock Movers
Aethlon Medical (NASDAQ: AEMD) 370% HIGHER; WSB/Reddit meme trade.
ContextLogic Inc. (NASDAQ: WISH) 26.6% HIGHER; WSB/Reddit meme trade.
Solid Biosciences Inc. (Nasdaq: SLDB) 25% HIGHER; sees upside gains.
Clover Health (NASDAQ: CLOV) 24.6% HIGHER; sees continued momentum on WSB/Reddit meme trade
Lyra Therapeutics, Inc. (Nasdaq: LYRA) 11% HIGHER; announced the successful outcome of an End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) for LYR-210, its lead candidate for the treatment of chronic rhinosinusitis (CRS).
Ondas Holdings Inc. (NASDAQ: ONDS) 14.7% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering
Campbell Soup (NYSE: CPB) 8.5% LOWER; reported Q3 EPS of $0.57, $0.09 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $2 billion. Campbell Soup sees FY2021 EPS of $2.90-$2.93, versus the consensus of $3.07.
Comtech Telecom (NASDAQ: CMTL) 8% LOWER; reported Q3 EPS of $0.26, $0.27 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $139.4 million versus the consensus estimate of $140.39 million.
UiPath Inc. (NYSE: PATH) 7.9% LOWER; reported Q1 EPS of $0.02, versus ($0.09) reported last year. Revenue for the quarter came in at $186.2 million, versus $113.1 million reported last year. UiPath Inc. sees Q2 2022 revenue of $180-185 million.
Clarivate Plc (NYSE: CLVT) 7.6% LOWER; announced today that it has commenced concurrent proposed offerings of $750 million of ordinary shares, alongside which certain existing shareholders intend to offer $250 million of ordinary shares, and $1.25 billion of Series A Mandatory Convertible preferred shares.
Lordstown Motors (NASDAQ: RIDE) 4.7% LOWER; RBC Capital initiated coverage with an Underperform rating and a price target of $5.00.
Option Care Health, Inc. (NASDAQ: OPCH) 4.2% LOWER; announced today that an affiliate of Madison Dearborn Partners has agreed to sell 10,000,000 shares of the Company’s common stock in an underwritten public offering
Calavo Growers (NASDAQ: CVGW) 3.9% LOWER; reported Q2 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $276.8 million versus the consensus estimate of $267.07 million. The Company is providing the following expectations for the third fiscal quarter of 2021: Revenue in a range of $280 million to $300 million; and Adjusted EBITDA in a range of $11 million to $15 million.
CEL-SCI Corporation (NYSE: CVM) 3.6% LOWER; agreed to purchase on a firm commitment basis a minimum of 1,000,000 shares of common stock of the Company, at a price to the public of $22.62 per share (the “Public Price”), representing a 5% discount to the Company’s June 8, 2021 closing share price.
Fisker (NYSE: FSR) 3.5% HIGHER; RBC Capital initiates coverage with an Outperform rating and a price target of $27.00.
Limoneira (NASDAQ: LMNR) 3.5% HIGHER; reported Q2 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $45.1 million versus the consensus estimate of $45.44 million.
8x8, Inc. (NYSE: EGHT) 3.5% HIGHER; CEO, David Sipes, bought 43,000 shares on 06/07 at $23.47.
Abercrombie & Fitch (NYSE: ANF) 3.3% HIGHER; Jefferies upgraded from Hold to Buy with a price target of $57.00 (from $46.00).
Dish Network (NASDAQ: DISH) 2.6% LOWER; JPMorgan downgraded from Neutral to Underweight with a price target of $45.00 (from $38.00).
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) 2% HIGHER; announced that the U.S Patent and Trademark Office issued a patent covering methods of using ARCALYST® (rilonacept) in the treatment of recurrent pericarditis.
Aclaris Therapeutics, Inc. (Nasdaq: ACRS) 2% LOWER; announced that it intends to offer and sell, subject to market conditions, $75 million in shares of its common stock in an underwritten public offering
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 06/18: (CAI) (SKKE) (GERN) Higher; (ORPH) (ATHA) (CGRN) Lower (more...)
- Pre-Open Stock Movers 06/15: (CLSD) (OCGN) (AMPE) Higher; (PDSB) (PTGX) (PING) Lower (more...)
- MagnaChip (MX) Falls After Being Told to Pause Merger Amid CFIUS Review
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesJPMorgan, Jefferies & Co, RBC Capital, Madison Dearborn Partners, Pre-Open Losers, Pre-Open Winners, Pre Market Movers, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!